基于CT影像组学的甲状腺乳头状癌术后131I疗效预后分析
研究纳入181例接受全甲状腺切除术及首次131I治疗的甲状腺乳头状癌患者,按7:3分为训练集与测试集,构建临床模型、影像组学模型及联合模型预测131I疗效。多因素分析显示131I治疗前血清甲状腺球蛋白是独立临床危险因素(P=0.002),其预测AUC、敏感度、特异度分别为0.895、0.899、0.816。联合模型在训练集和测试集中均较影像组学模型提高了AUC、敏感度和特异度。
要点
- 131I治疗前血清甲状腺球蛋白是影响首次131I疗效的独立临床危险因素(P=0.002)。
- 基于术前CT的影像组学模型可预测中高危甲状腺乳头状癌术后首次131I疗效。
- 影像组学-临床联合模型较影像组学模型预测性能更好。
核心结论
- 基于术前CT的影像组学模型可有效预测中危或高危甲状腺乳头状癌患者术后首次131I治疗的疗效,影像组学-临床联合模型表现出更好的预测性能。
研究设计与样本
- 回顾性纳入181例接受全甲状腺切除术及首次131I治疗的甲状腺乳头状癌患者,按7:3比例分为训练集与测试集。
- 采用单因素分析及多因素logistic回归筛选影响131I治疗疗效的临床因素并构建临床模型。
- 从术前CT图像提取影像组学特征,经递归特征消除和最小绝对收缩与选择算子降维后,用logistic回归建立影像组学模型,并整合临床模型构建联合模型。
- 采用曲线下面积(AUC)、敏感度和特异度评价各模型预测性能。
主要发现
- 多因素分析显示,131I治疗前血清甲状腺球蛋白是影响首次131I治疗疗效的独立临床危险因素(P=0.002),其预测AUC、敏感度、特异度分别为0.895、0.899、0.816。
- 降维后纳入14个关键CT影像组学特征。
- 影像组学模型在训练集和测试集中预测131I疗效的AUC分别为0.825和0.809,敏感度分别为0.828和0.636,特异度分别为0.745和0.944。
- 联合模型在训练集和测试集中均提高了AUC、敏感度和特异度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate a radiomics-clinical combined model combining preoperative computed tomography (CT) and clinical data from patients with papillary thyroid carcinoma (PTC) to predict the efficacy of initial postoperative 131I treatment. METHODS: A total of 181 patients with PTC who received total thyroidectomy and initial 131I treatment were divided into training and testing sets (7:3 ratio). Univariate analysis and multivariate logistic regression were used to screen clinical factors affecting the therapeutic response to 131I treatment and construct a clinical model. Radiomics features extracted from preoperative CT images of PTCs were dimensionally reduced through recursive feature elimination and least absolute shrinkage and selection operator. Logistic regression was used to establish a radiomics model, and a radiomics-clinical combined model was developed by integrating the clinical model. The area under the curve (AUC), sensitivity, and specificity were used to evaluate the prediction performance of each model. RESULTS: Multivariate analysis revealed that pre-131I treatment serum thyroglobulin was an independent clinical risk factor affecting the efficacy of initial 131I treatment (P = .002), and the AUC, sensitivity, and specificity for predicting the efficacy of initial 131I treatment were 0.895, 0.899, and 0.816, respectively. After dimensionality reduction, 14 key CT radiomics features of PTCs were included. The established radiomics model predicted the efficacy of 131I treatment in the training and testing sets with AUCs of 0.825 and 0.809, sensitivities of 0.828 and 0.636, and specificities of 0.745 and 0.944, respectively. The combined model improved the AUC, sensitivity, and specificity in both sets. CONCLUSION: The preoperative CT-based radiomics model can effectively predict the efficacy of initial postoperative 131I treatment in patients with intermediate- or high-risk PTC, and the radiomics-clinical combined model exhibits better predictive performance.
引用
- Cao H, Shangguan L, Zhu H, et al. Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics. J Clin Endocrinol Metab. 2024. PMID: 38801437. doi:10.1210/clinem/dgae364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。